药品注册申请号:050609
申请类型:NDA (新药申请)
申请人:HOSPIRA
申请人全名:HOSPIRA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 ERYTHROCIN ERYTHROMYCIN LACTOBIONATE INJECTABLE;INJECTION EQ 500MG BASE/VIAL Yes Yes AP 1986/09/24 1986/09/24 Prescription
002 ERYTHROCIN ERYTHROMYCIN LACTOBIONATE INJECTABLE;INJECTION EQ 1GM BASE/VIAL Yes No None 1986/09/24 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2022/11/18 SUPPL-51(补充) Approval Labeling STANDARD
2019/11/05 SUPPL-41(补充) Approval Labeling STANDARD
2018/04/23 SUPPL-39(补充) Approval Labeling STANDARD
2015/10/27 SUPPL-36(补充) Approval Manufacturing (CMC) STANDARD
2015/04/22 SUPPL-35(补充) Approval Manufacturing (CMC) STANDARD
2013/08/19 SUPPL-34(补充) Approval Labeling STANDARD Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.
2012/02/02 SUPPL-33(补充) Approval Labeling STANDARD
2011/06/09 SUPPL-32(补充) Approval Labeling STANDARD
2008/02/26 SUPPL-25(补充) Approval Labeling STANDARD
2004/09/16 SUPPL-19(补充) Approval Labeling STANDARD
2002/12/13 SUPPL-18(补充) Approval Manufacturing (CMC) STANDARD
2002/08/29 SUPPL-17(补充) Approval Manufacturing (CMC) STANDARD
2002/05/23 SUPPL-15(补充) Approval Labeling STANDARD
2001/03/20 SUPPL-16(补充) Approval Manufacturing (CMC) STANDARD
1999/11/08 SUPPL-14(补充) Approval Manufacturing (CMC) STANDARD
1997/10/27 SUPPL-11(补充) Approval Manufacturing (CMC) STANDARD
1996/03/18 SUPPL-10(补充) Approval Manufacturing (CMC) STANDARD
1994/08/24 SUPPL-8(补充) Approval Labeling
1994/08/24 SUPPL-7(补充) Approval Labeling
1993/03/12 SUPPL-9(补充) Approval Labeling
1991/12/05 SUPPL-6(补充) Approval Manufacturing (CMC) STANDARD
1987/09/21 SUPPL-2(补充) Approval Labeling
1986/09/24 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:ERYTHROMYCIN LACTOBIONATE 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 500MG BASE/VIAL 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
050609 001 NDA ERYTHROCIN ERYTHROMYCIN LACTOBIONATE INJECTABLE;INJECTION EQ 500MG BASE/VIAL Prescription Yes Yes AP 1986/09/24 HOSPIRA
062638 001 ANDA ERYTHROCIN ERYTHROMYCIN LACTOBIONATE INJECTABLE;INJECTION EQ 500MG BASE/VIAL Prescription No No AP 1986/10/31 HOSPIRA
211086 001 ANDA ERYTHROMYCIN LACTOBIONATE ERYTHROMYCIN LACTOBIONATE INJECTABLE;INJECTION EQ 500MG BASE/VIAL Discontinued No No AP 2020/09/17 EXELA PHARMA
215290 001 ANDA ERYTHROMYCIN LACTOBIONATE ERYTHROMYCIN LACTOBIONATE INJECTABLE;INJECTION EQ 500MG BASE/VIAL Prescription No No AP 2022/02/14 NEXUS
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database